We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cigna (CI) Dips More Than Broader Markets: What You Should Know
Read MoreHide Full Article
In the latest trading session, Cigna (CI - Free Report) closed at $206.69, marking a -1.75% move from the previous day. This move lagged the S&P 500's daily loss of 1.73%. Elsewhere, the Dow lost 1.19%, while the tech-heavy Nasdaq lost 2.07%.
Heading into today, shares of the health insurer had gained 1.95% over the past month, outpacing the Finance sector's loss of 7.4% and the S&P 500's loss of 7.09% in that time.
Wall Street will be looking for positivity from CI as it approaches its next earnings report date. This is expected to be November 1, 2018. On that day, CI is projected to report earnings of $3.45 per share, which would represent year-over-year growth of 21.91%. Our most recent consensus estimate is calling for quarterly revenue of $11.22 billion, up 9.28% from the year-ago period.
CI's full-year Zacks Consensus Estimates are calling for earnings of $13.87 per share and revenue of $45.38 billion. These results would represent year-over-year changes of +32.6% and +9.67%, respectively.
Investors should also note any recent changes to analyst estimates for CI. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0% lower within the past month. CI is currently a Zacks Rank #3 (Hold).
Looking at its valuation, CI is holding a Forward P/E ratio of 15.17. This valuation marks a premium compared to its industry's average Forward P/E of 11.63.
Meanwhile, CI's PEG ratio is currently 1.24. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. CI's industry had an average PEG ratio of 1.18 as of yesterday's close.
The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 155, which puts it in the bottom 39% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cigna (CI) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Cigna (CI - Free Report) closed at $206.69, marking a -1.75% move from the previous day. This move lagged the S&P 500's daily loss of 1.73%. Elsewhere, the Dow lost 1.19%, while the tech-heavy Nasdaq lost 2.07%.
Heading into today, shares of the health insurer had gained 1.95% over the past month, outpacing the Finance sector's loss of 7.4% and the S&P 500's loss of 7.09% in that time.
Wall Street will be looking for positivity from CI as it approaches its next earnings report date. This is expected to be November 1, 2018. On that day, CI is projected to report earnings of $3.45 per share, which would represent year-over-year growth of 21.91%. Our most recent consensus estimate is calling for quarterly revenue of $11.22 billion, up 9.28% from the year-ago period.
CI's full-year Zacks Consensus Estimates are calling for earnings of $13.87 per share and revenue of $45.38 billion. These results would represent year-over-year changes of +32.6% and +9.67%, respectively.
Investors should also note any recent changes to analyst estimates for CI. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0% lower within the past month. CI is currently a Zacks Rank #3 (Hold).
Looking at its valuation, CI is holding a Forward P/E ratio of 15.17. This valuation marks a premium compared to its industry's average Forward P/E of 11.63.
Meanwhile, CI's PEG ratio is currently 1.24. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. CI's industry had an average PEG ratio of 1.18 as of yesterday's close.
The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 155, which puts it in the bottom 39% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.